{
     "PMID": "12213311",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20021127",
     "LR": "20161124",
     "IS": "0006-8993 (Print) 0006-8993 (Linking)",
     "VI": "949",
     "IP": "1-2",
     "DP": "2002 Sep 13",
     "TI": "Cyclic AMP-mediated modulation of epileptiform afterdischarge generation in rat hippocampal slices.",
     "PG": "157-61",
     "AB": "This study assessed the effects of drugs which manipulate the cAMP system on afterdischarges (ADs) induced in the CA1 region of rat hippocampal slices. The adenylate cyclase activator forskolin (50 microM) and the phosphodiesterase inhibitor rolipram (0.1 and 1 microM) enhanced AD generation. These effects were reversed by the cAMP-dependent protein kinase inhibitors H-89 (5 microM) and Rp-cAMPS (100 microM). These findings suggest that AD generation can be modulated through cAMP generation and the subsequent activation of the cAMP-dependent protein kinase.",
     "CI": [
          "Copyright 2002 Elsevier Science B.V."
     ],
     "FAU": [
          "Higashima, Masato",
          "Ohno, Koji",
          "Koshino, Yoshifumi"
     ],
     "AU": [
          "Higashima M",
          "Ohno K",
          "Koshino Y"
     ],
     "AD": "Department of Psychiatry and Neurobiology, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan. mtohma@med.kanazawa-u.ac.jp",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "Netherlands",
     "TA": "Brain Res",
     "JT": "Brain research",
     "JID": "0045503",
     "RN": [
          "0 (Enzyme Activators)",
          "0 (Enzyme Inhibitors)",
          "0 (Isoquinolines)",
          "0 (Phosphodiesterase Inhibitors)",
          "0 (Sulfonamides)",
          "0 (Thionucleotides)",
          "1F7A44V6OU (Colforsin)",
          "23645-17-2 (adenosine-3',5'-cyclic phosphorothioate)",
          "E0399OZS9N (Cyclic AMP)",
          "EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases)",
          "EC 4.6.1.1 (Adenylyl Cyclases)",
          "K676NL63N7 (Rolipram)",
          "M876330O56 (N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide)"
     ],
     "SB": "IM",
     "MH": [
          "Action Potentials/drug effects",
          "Adenylyl Cyclases/metabolism",
          "Animals",
          "Colforsin/pharmacology",
          "Cyclic AMP/*analogs & derivatives/*metabolism/pharmacology",
          "Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors/metabolism",
          "Electrophysiology",
          "Enzyme Activators/pharmacology",
          "Enzyme Inhibitors/pharmacology",
          "Epilepsy/metabolism",
          "Hippocampus/*drug effects/*metabolism",
          "Isoquinolines/pharmacology",
          "Male",
          "Phosphodiesterase Inhibitors/pharmacology",
          "Rats",
          "Rats, Sprague-Dawley",
          "Rolipram/pharmacology",
          "Seizures/*metabolism",
          "*Sulfonamides",
          "Thionucleotides/pharmacology"
     ],
     "EDAT": "2002/09/06 10:00",
     "MHDA": "2002/11/28 04:00",
     "CRDT": [
          "2002/09/06 10:00"
     ],
     "PHST": [
          "2002/09/06 10:00 [pubmed]",
          "2002/11/28 04:00 [medline]",
          "2002/09/06 10:00 [entrez]"
     ],
     "AID": [
          "S0006899302029761 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Brain Res. 2002 Sep 13;949(1-2):157-61.",
     "term": "hippocampus"
}